View in EDS HTML Full Text PDF Full Text

Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.

Saved in:
Bibliographic Details
Title: Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
Authors: Sadowski C; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA., Belknap R; Denver Metro Tuberculosis Program, Denver Public Health, Denver, Colorado, USA., Holland DP; Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA., Moro RN; CDC Foundation, Research Collaboration, Atlanta, Georgia, USA.; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Chen MP; Immunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Wright A; Division of Infectious Diseases, Vanderbilt University Medical Centers, Nashville, Tennessee, USA., Millet JP; Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.; Foundation of Tuberculosis Research Unit of Barcelona, Barcelona, Spain., Caylà JA; Foundation of Tuberculosis Research Unit of Barcelona, Barcelona, Spain., Scott NA; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Borisov A; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gandhi NR; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jun 16; Vol. 76 (12), pp. 2090-2097.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36815322
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sadowski+C%22">Sadowski C</searchLink>; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Belknap+R%22">Belknap R</searchLink>; Denver Metro Tuberculosis Program, Denver Public Health, Denver, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Holland+DP%22">Holland DP</searchLink>; Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Moro+RN%22">Moro RN</searchLink>; CDC Foundation, Research Collaboration, Atlanta, Georgia, USA.; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Chen+MP%22">Chen MP</searchLink>; Immunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Wright+A%22">Wright A</searchLink>; Division of Infectious Diseases, Vanderbilt University Medical Centers, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Millet+JP%22">Millet JP</searchLink>; Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.; Foundation of Tuberculosis Research Unit of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Caylà+JA%22">Caylà JA</searchLink>; Foundation of Tuberculosis Research Unit of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Scott+NA%22">Scott NA</searchLink>; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Borisov+A%22">Borisov A</searchLink>; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Gandhi+NR%22">Gandhi NR</searchLink>; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2023 Jun 16; Vol. 76 (12), pp. 2090-2097.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36815322
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciad083
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2090
    Titles:
      – TitleFull: Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sadowski C
      – PersonEntity:
          Name:
            NameFull: Belknap R
      – PersonEntity:
          Name:
            NameFull: Holland DP
      – PersonEntity:
          Name:
            NameFull: Moro RN
      – PersonEntity:
          Name:
            NameFull: Chen MP
      – PersonEntity:
          Name:
            NameFull: Wright A
      – PersonEntity:
          Name:
            NameFull: Millet JP
      – PersonEntity:
          Name:
            NameFull: Caylà JA
      – PersonEntity:
          Name:
            NameFull: Scott NA
      – PersonEntity:
          Name:
            NameFull: Borisov A
      – PersonEntity:
          Name:
            NameFull: Gandhi NR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 06
              Text: 2023 Jun 16
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 76
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1